Angioplasty, Transluminal, Percutaneous Coronary

Cardiovascular
3
Pipeline Programs
2
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
1
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

C
CordisFL - Miami Lakes
3 programs
1
1
1
Manual CompressionPhase 31 trial
Vascular access site closurePhase 21 trial
7F Ensure Medical Vascular Closure DevicePhase 11 trial
Active Trials
NCT00574691Completed93Est. Oct 2007
NCT00533156Completed30Est. Aug 2007
NCT00345631Completed488Est. Sep 2007
Biotronik
BiotronikGermany - Berlin
1 program
Orsiro™ Drug Eluting Stent groupN/A1 trial
Active Trials
NCT02039739Completed1,007Est. Jan 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
CordisManual Compression
CordisVascular access site closure
Cordis7F Ensure Medical Vascular Closure Device
BiotronikOrsiro™ Drug Eluting Stent group

Clinical Trials (4)

Total enrollment: 1,618 patients across 4 trials

NCT00345631CordisManual Compression

Safety and Effectiveness Study of the Ensure Medical Vascular Closure Device

Start: Feb 2007Est. completion: Sep 2007488 patients
Phase 3Completed
NCT00533156CordisVascular access site closure

Plug Arterial Closure System (PACS, 7F)

Start: Jul 2007Est. completion: Aug 200730 patients
Phase 2Completed
NCT00574691Cordis7F Ensure Medical Vascular Closure Device

ECLIPSE Feasibility Trial (Ensure's Vascular Closure Device Speeds Hemostasis Trial) EU

Start: Jun 2007Est. completion: Oct 200793 patients
Phase 1Completed
NCT02039739BiotronikOrsiro™ Drug Eluting Stent group

Orsiro™ Drug Eluting Stent in Routine Clinical Practice

Start: Jun 2014Est. completion: Jan 20221,007 patients
N/ACompleted

Related Jobs in Cardiovascular

Embedded Software and System Test Engineer (H/F)

Cardiawave
Levallois-Perret, France (Hybrid)
Just now

Territory Sales Manager - Iowa / Nebraska

HeartFlow
Cedar Rapids, IA; Des Moines, IA; Omaha, NE; Lincoln, NE
Yesterday
From $150K/yr

Associate Regulatory Affairs Specialist

Medtronic
Mounds View, Minnesota, United States of America
Yesterday
$60K - $90K/yr

Business Development Manager, Post Transplant, Cardio Thoracic

Thermo Fisher Scientific
Remote
Yesterday

Director, Medical Affairs

Abbott
Germany - Hesse - Eschborn
Yesterday

Therapy Development Manager

Abbott
Australia > Doncaster : 666 Doncaster Road
Yesterday

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
2 companies competing in this space

Related Indications

Heart Failure(334)Hypertension(333)Coronary Artery Disease(295)Atrial Fibrillation(288)Pulmonary Arterial Hypertension(103)Acute Coronary Syndrome(62)Pulmonary Hypertension(55)Essential Hypertension(32)Coronary Heart Disease(28)Aortic Valve Stenosis(27)